Cover Image
市場調查報告書

輸尿管癌:全球臨床實驗檢討

Ureter Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 301162
出版日期 內容資訊 英文 89 Pages
訂單完成後即時交付
價格
Back to Top
輸尿管癌:全球臨床實驗檢討 Ureter Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月30日 內容資訊: 英文 89 Pages
簡介

本報告提供輸尿管癌治療藥相關的臨床實驗調查分析,提供臨床實驗數及被實驗人數,階段及Phase別狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗上輸尿管癌的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:腫瘤科臨床實驗上輸尿管癌的比例

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與輸尿管癌治療藥臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • 武田藥品工業
    • Oncogenex Pharmaceuticals, Inc.
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • Eisai
    • AstraZeneca PLC
    • Amgen Inc.
    • Altor BioScience Corporation
    • Across Barriers GmbH
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • Southwest Oncology Group
    • National Bladder Cancer Collaborative Group
    • European Organization for Research and Treatment of Cancer
    • University of California, Davis
    • The University of Texas M. D. Anderson Cancer Center
    • Mayo Clinic
    • Medical Research Council
    • Princess Margaret Hospital

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2109CTIDB

GlobalData's clinical trial report, "Ureter Cancer Global Clinical Trials Review, H1, 2014" provides data on the Ureter Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ureter Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ureter Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ureter Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ureter Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ureter Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ureter Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ureter Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Oncogenex Pharmaceuticals, Inc.
      • Clinical Trial Overview of Oncogenex Pharmaceuticals, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Altor BioScience Corporation
      • Clinical Trial Overview of Altor BioScience Corporation
      • Across Barriers GmbH
      • Clinical Trial Overview of Across Barriers GmbH
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Southwest Oncology Group
      • Clinical Trial Overview of Southwest Oncology Group
      • National Bladder Cancer Collaborative Group
      • Clinical Trial Overview of National Bladder Cancer Collaborative Group
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • University of California, Davis
      • Clinical Trial Overview of University of California, Davis
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
      • Princess Margaret Hospital
      • Clinical Trial Overview of Princess Margaret Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ureter Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Ureter Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ureter Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ureter Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Ureter Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Ureter Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ureter Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Altor BioScience Corporation, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Across Barriers GmbH, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Bladder Cancer Collaborative Group, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014*
  • Ureter Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2014*

List of Figures

  • Ureter Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Ureter Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Ureter Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ureter Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ureter Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Ureter Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ureter Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ureter Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top